Asthma and the predisposition to produce IgE are inherited as linked traits
in families. In patients IgE levels correlate with asthma severity and bro
nchial hyperresponsiveness. The concept that IgE plays a critical role in a
sthma pathogenesis has driven the development of IgE blockers, which are cu
rrently being introduced into clinical use. This review focuses on the mech
anisms whereby IgE participates both in immediate hypersensitivity response
s in the airways and in the induction of chronic allergic bronchial inflamm
ation. The molecular genetic events that give rise to IgE production by B c
ells and the cellular and cytokine factors that support IgE production in t
he bronchial mucosal microenvironment are discussed. It is clear that much
remains to be learned regarding the roles of IgE in asthma and the genetic
and environmental influences that lead to its production. Over the next few
years, the emerging experience with anti-IgE in patients mill provide a mo
re complete understanding of the mechanisms whereby IgE contributes to dise
ase, as well as the therapeutic potential of its inhibition.